Clinical Trial Update: A Drug Monitoring Study on PEG-asparaginase Treatment in Children Diagnosed Acute Lymphoblastic Leukaemia

View source ↗

Summary

This document reports on a drug monitoring study evaluating PEG-asparaginase in children with acute lymphoblastic leukemia; the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Pegaspargase (pegaspargase)

Snippet

Sponsor: Aarhus University Hospital | Conditions: Acute Lymphoblastic Leukaemia | Status: UNKNOWN